Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus
| العنوان: | Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus |
|---|---|
| المؤلفون: | Shufang Yang, Li He, Sujing Zhang, Liping Zhao, Na Li, Yonghui An, Yingchun Zhao, Wenhua Ma, Changwen Bo, Zheng Zheng |
| المصدر: | Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021) Radiation Oncology (London, England) |
| بيانات النشر: | BMC, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, Male, Organs at Risk, medicine.medical_specialty, endocrine system, Carcinoma, Hepatocellular, Stereotactic body radiation therapy, medicine.medical_treatment, Portal vein, R895-920, Radiosurgery, Medical physics. Medical radiology. Nuclear medicine, Quality of life, Clinical outcomes, Humans, Medicine, Portal vein tumor thrombus, Radiology, Nuclear Medicine and imaging, Adverse effect, Survival rate, RC254-282, Retrospective Studies, Portal Vein, business.industry, Research, Radiotherapy Planning, Computer-Assisted, Liver Neoplasms, Primary liver cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Radiotherapy Dosage, Thrombosis, Retrospective cohort study, Prognosis, Survival Rate, Radiation therapy, Oncology, Female, Radiotherapy, Intensity-Modulated, Radiology, Fractionated radiation therapy, business, Follow-Up Studies |
| الوصف: | Background To compare the clinical outcomes of stereotactic body radiation therapy (SBRT) and fractionated radiation therapy (FRT) for primary liver cancer with portal vein tumor thrombus (PVTT). Methods This retrospective study included 36 patients who underwent SBRT and 36 patients who underwent FRT from August 2016 to June 2018. Patients were evaluated for short-term efficacy, long-term efficacy, AEs, and quality of life before and after treatment. Results With a median follow-up of 28.8 months (26–36 months), 27 patients survived in the SBRT group while 19 patients survived in the FRT group. The survival rate in the SBRT group was statistically higher than that of the FRT group after 6 months (80.56% vs. 58.33%; P = 0.041), 12 months (77.78% vs. 55.56%; P = 0.046) and 24 months 75.00% vs. 52.78%; P = 0.049). The median whole survival time of the SBRT group was 13.3 months (95% CI 12.83–13.97), which was statistically longer than 9.8 months in the FRT group (95% CI 8.83–10.97, P Conclusion SBRT had better clinical outcomes than FRT for primary liver cancer with PVTT. |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fc941d4ea2c5a1925ae4fc8fe4b369 https://doaj.org/article/722626cd424348919155f68480afa3a0 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....c4fc941d4ea2c5a1925ae4fc8fe4b369 |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |